| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 16 Jan 25 | SAGE Sage Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 6.97 | 174,000 | 1.21 mm | 174,000 |
| 5 Aug 24 | SAGE Sage Therapeutics | Common Stock | Payment of exercise | Dispose F | No | No | 8.96 | 12,273 | 109.97 k | 85,067 |
| 5 Aug 24 | SAGE Sage Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 50,400 | 0.00 | 97,340 |
| 29 May 24 | KPTI Karyopharm Therapeutics | Nonstatutory Stock Option Common Stock | Grant | Acquire A | No | No | 0.96 | 69,000 | 66.24 k | 69,000 |
| 13 Feb 24 | SAGE Sage Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 23.02 | 168,000 | 3.87 mm | 168,000 |
| 4 Aug 23 | SAGE Sage Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 85.82 | 195,000 | 16.73 mm | 195,000 |
